Skip to content
Screener

Kodiak Sciences Inc KOD Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$37.8M+24.8%
EyePoint, Inc. logo
EyePoint, Inc.EYPT
$2.55M+34.4%
KLR
Kalaris TherapeuticsKLRS
$317K
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$5.49M-3.4%
HRO
HarrowHROW
$944K+20.7%
PVL
Palvella TherapeuticsPVLA
$209K

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.84B+570%
Enterprise value$2.73B+608%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The source filing: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211951
Line itemMarch 31,2026December 31,2025
Current liabilities:
Accounts payable$11,344$12,863
Accrued and other current liabilities26,56920,607
Operating lease liability11,66012,063
Total current liabilities49,57345,533
Long-term operating lease liability44,33247,117
Liability related to sale of future royalties100,000100,000
Long-term deposit1,500

Item 1. Financial Statements (Unaudited).

FAQ

What is Kodiak Sciences Inc's operating lease liabilities (current)?
Kodiak Sciences Inc (KOD) reported operating lease liabilities (current) of $11.66M in Q1 2026.
How has Kodiak Sciences Inc's operating lease liabilities (current) changed year-over-year?
Kodiak Sciences Inc's operating lease liabilities (current) increased by 6.5% year-over-year, from $10.95M to $11.66M.
What is the long-term trend for Kodiak Sciences Inc's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's operating lease liabilities (current) has grown at a 38.4% compound annual growth rate (CAGR), from $2.37M to $12.06M.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.

Ask your AI about Kodiak Sciences Inc's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude